ARCHIVES

NCAB Working Group Appointed To Review NCI Progress

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Obama Signs Cigarette Tax Increase Into Law

February 13, 2009

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

Letter to the Editor

February 21, 2003

NCI Funding Notice.

July 4, 2003